Caxton Associates (UK)’s Humana HUM Stock Holding History
Bought
Maintained
Sold
Other funds holding HUM
SC
Caxton Associates (UK)'s HUM Position: Q2 2026 in Review
Caxton Associates (UK) increased its Humana (HUM) stake by 54% in Q2 2026, buying an estimated $875K and bringing the position to 8,720 shares worth $3.46M. The position accounts for 0.07% of the portfolio, ranked #136.
Caxton Associates (UK) first reported a position in HUM in Q1 2025 and has held it in 3 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Caxton Associates (UK) held 8,720 shares of Humana worth $3.46M as of Q2 2026.
- Caxton Associates (UK) bought 3,074 Humana shares in Q2 2026, an estimated $875K.
- Humana made up 0.07% of Caxton Associates (UK)'s portfolio in Q2 2026, its #136 holding.
- Caxton Associates (UK) first reported a position in Humana in Q1 2025 and has held it in 3 quarters since.
- 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.